Skip to content
Screener

Liquidia Corporation LQDA Financing Cash Flow

Financing Cash Flow at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
-$1.18B-18.4%
Mannkind logo
MannkindMNKD
-$35.41M-2,647%
United Therapeutics logo
United TherapeuticsUTHR
-$1.48B-1,483%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$211.44M+2,334%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$5.58M-553%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$549.89M+812%

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$7.93B+356%
Enterprise value$7.71B+391%
P/S27.5×-62.3×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Liquidia Corporation in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Liquidia Corporation’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 7:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-058252
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Principal payments on finance leases(64)
Receipts from litigation financing163235
Proceeds from issuance of common stock under stock incentive plans1,7521,264
Net cash provided by (used in) financing activities(18,054)24,288
Net increase (decrease) in cash, cash equivalents, and restricted cash32,106(6,721)
Cash, cash equivalents, and restricted cash, beginning of period194,184176,479
Cash, cash equivalents, and restricted cash, end of period$226,290$169,758
Supplemental disclosure of cash flow information

Item 1. Condensed Financial Statements (unaudited)

FAQ

What is Liquidia Corporation's financing cash flow?
Liquidia Corporation (LQDA) reported financing cash flow of -$18.05M in Q1 2026.
How has Liquidia Corporation's financing cash flow changed year-over-year?
Liquidia Corporation's financing cash flow decreased by 174.3% year-over-year, from $24.29M to -$18.05M.
What is the long-term trend for Liquidia Corporation's financing cash flow?
Over 2 years (2021 to 2023), Liquidia Corporation's financing cash flow has grown at a 28.8% compound annual growth rate (CAGR), from $26.32M to $43.66M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Liquidia Corporation's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude